​

Baxter (BAX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BAX Stock Forecast

Baxter (BAX) stock forecast, based on 26 Wall Street analysts, predicts a 12-month average price target of $43.00, with a high of $45.00 and a low of $42.00. This represents a 31.18% increase from the last price of $32.78.

$25 $30 $35 $40 $45 $50 High: $45 Avg: $43 Low: $42 Last Closed Price: $32.78

BAX Stock Rating

Baxter stock's rating consensus is Hold, based on 26 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (42.31%), 14 Hold (53.85%), 1 Sell (3.85%), and 0 Strong Sell (0.00%).

Hold
Total 26 1 14 11 Strong Sell Sell Hold Buy Strong Buy

BAX Forecast vs Benchmarks

TypeNameUpside
StockBaxter31.18%
SectorHealthcare Stocks 25.20%
IndustryMedical Instruments & Supplies Stocks19.92%

Price Target Trends

1M3M12M
# Anlaysts118
Avg Price Target$42.00$42.00$40.25
Last Closing Price$32.78$32.78$32.78
Upside/Downside28.13%28.13%22.79%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25-3121-16
Dec, 24-3121-16
Nov, 2424111-18
Oct, 2424121-19
Sep, 2424121-19
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 02, 2025Vijay KumarEvercore ISI$42.00$29.2643.54%28.13%
Oct 04, 2024Travis SteedBank of America Securities$45.00$36.3223.90%37.28%
Aug 06, 2024Matthew TaylorJefferies$42.00$36.9213.76%28.13%
Jul 15, 2024Patrick WoodMorgan Stanley$30.00$35.32-15.06%-8.48%
Jun 12, 2024David RomanGoldman Sachs$36.00$33.318.08%9.82%
May 03, 2024Danielle AntalffyUBS$40.00$36.918.37%22.03%
May 02, 2024Matthew TaylorJefferies$43.00$36.8916.56%31.18%
May 02, 2024Rick WiseStifel Nicolaus$44.00$36.7319.79%34.23%
Jul 31, 2023Matt MiksicBarclays$54.00$45.2619.31%64.73%
Jul 31, 2023Philippe HouchoisJefferies$85.00$47.0180.81%159.30%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Jan 02, 2025Evercore ISIOutperformOutperformhold
Sep 30, 2024Deutsche BankHoldHoldhold
Aug 06, 2024JefferiesHoldHoldhold
Jul 15, 2024Morgan StanleyEqual-WeightUnderweightdowngrade
Jun 12, 2024Goldman SachsNeutralNeutralhold
May 30, 2024Goldman SachsBuyNeutralinitialise
May 22, 2024CitigroupNeutralNeutralhold
May 10, 2024Cowen & Co.Sector WeightHolddowngrade
May 03, 2024UBSNeutralNeutralhold
May 02, 2024JefferiesHoldHoldhold

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 $2 $3 $4 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.17$2.56$-4.80$-0.45-----
Avg Forecast$3.06$3.60$3.56$2.59$1.83$2.47$2.72$3.15$3.40
High Forecast$3.04$3.57$3.48$2.58$1.82$2.40$2.63$3.05$3.30
Low Forecast$3.07$3.62$3.60$2.60$1.84$2.54$2.83$3.20$3.46
Surprise %-29.08%-28.89%-234.83%-117.37%-----

Revenue Forecast

$11B $12B $13B $14B $15B $16B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$11.67B$12.78B$15.11B$14.81B-----
Avg Forecast$11.58B$12.57B$15.00B$14.74B$10.56B$11.22B$11.71B$12.30B$12.84B
High Forecast$11.53B$12.51B$14.75B$14.72B$10.52B$11.00B$11.70B$12.27B$12.56B
Low Forecast$11.63B$12.63B$15.14B$14.82B$10.58B$11.34B$11.72B$12.33B$13.00B
Surprise %0.78%1.70%0.77%0.49%-----

Net Income Forecast

$-3B $-1B $-300M $800M $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.10B$1.28B$-2.42B$2.66B-----
Avg Forecast$1.02B$1.17B$1.02B$-76.00M$924.32M$1.25B$1.38B$1.58B$1.72B
High Forecast$817.34M$935.04M$818.87M$-91.20M$919.27M$1.21B$1.33B$1.55B$1.67B
Low Forecast$1.23B$1.40B$1.23B$-60.80M$929.37M$1.29B$1.43B$1.62B$1.75B
Surprise %7.86%9.86%-336.52%-3594.74%-----

BAX Forecast FAQ

Is Baxter stock a buy?

Baxter stock has a consensus rating of Hold, based on 26 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 14 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Baxter is a neutral investment for most analysts.

What is Baxter's price target?

Baxter's price target, set by 26 Wall Street analysts, averages $43 over the next 12 months. The price target range spans from $42 at the low end to $45 at the high end, suggesting a potential 31.18% change from the previous close price of $32.78.

How does Baxter stock forecast compare to the average forecast of its sector, industry, and investment themes?

Baxter stock forecast shows a 31.18% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the medical instruments & supplies stocks industry (19.92%).

What is the breakdown of analyst ratings for Baxter over the past three months?

  • January 2025: 0% Strong Buy, 18.75% Buy, 75.00% Hold, 6.25% Sell, 0% Strong Sell.
  • December 2024: 0% Strong Buy, 18.75% Buy, 75.00% Hold, 6.25% Sell, 0% Strong Sell.
  • November 2024: 11.11% Strong Buy, 22.22% Buy, 61.11% Hold, 5.56% Sell, 0% Strong Sell.

What is Baxter’s EPS forecast?

Baxter's average annual EPS forecast for its fiscal year ending in December is 1.83 for 2024, a -506.67% decrease from the reported $-0.45 in 2023. The prediction for 2025 is $2.47, $2.72 for 2026, $3.15 for 2027, and $3.4 for 2028.

What is Baxter’s revenue forecast?

Baxter's average annual revenue forecast for its fiscal year ending in December is $10.56B for 2024, a -28.73% decrease from the reported $14.81B in 2023. The forecast for 2025 is $11.22B, $11.71B for 2026, $12.3B for 2027, and $12.84B for 2028.

What is Baxter’s net income forecast?

For its fiscal year ending in December, Baxter's average annual net income forecast is $924.32M for 2024, reflecting a -65.20% decrease from the reported $2.66B in 2023. The projection for 2025 is $1.25B, $1.38B for 2026, $1.58B for 2027, and $1.72B for 2028.